These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9874590)

  • 21. Secondary prevention in concurrent coronary artery, cerebrovascular, and chronic kidney disease: focus on pharmacological therapy.
    Notaro LA; Usman MH; Burke JF; Siddiqui A; Superdock KR; Ezekowitz MD
    Cardiovasc Ther; 2009; 27(3):199-215. PubMed ID: 19689620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS
    Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice].
    De Caterina R
    Ital Heart J Suppl; 2001 Jun; 2(6):681-4. PubMed ID: 11460845
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment for blunt cerebrovascular injuries: equivalence of anticoagulation and antiplatelet agents.
    Cothren CC; Biffl WL; Moore EE; Kashuk JL; Johnson JL
    Arch Surg; 2009 Jul; 144(7):685-90. PubMed ID: 19620551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].
    Algra A; De Schryver EL; Halkes PH
    Ned Tijdschr Geneeskd; 2008 May; 152(20):1179; author reply 1180. PubMed ID: 18549147
    [No Abstract]   [Full Text] [Related]  

  • 27. Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).
    Aronow HD; Califf RM; Harrington RA; Vallee M; Graffagnino C; Shuaib A; Fitzgerald DJ; Easton JD; Van de Werf F; Diener HC; Ferguson J; Koudstaal PJ; Amarenco P; Theroux P; Davis S; Topol EJ
    Am J Cardiol; 2008 Nov; 102(10):1285-90. PubMed ID: 18993142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. By the way, doctor. My husband takes an aspirin every day to reduce his risk of another heart attack. I'm 60 and healthy. Is there any reason I shouldn't do the same to avoid a heart attack or stroke?
    Robb-Nicholson C
    Harv Womens Health Watch; 2004 Feb; 11(6):8. PubMed ID: 14980862
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secondary prophylaxis after cerebral infarction without cardiac source of embolism. Anticoagulants are not better than ASA according to a new extensive trial (WARSS)].
    Norrving B
    Lakartidningen; 2002 May; 99(20):2298-9. PubMed ID: 12082949
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolysis in stroke. An evaluation by the SBU Alert].
    Norrving DB; Britton DM; Asplund K
    Lakartidningen; 1999 Feb; 96(7):760-1. PubMed ID: 10087782
    [No Abstract]   [Full Text] [Related]  

  • 31. Does prior aspirin use reduce stroke mortality?
    Karlikaya G; Varlbas F; Demirkaya M; Orken C; Tireli H
    Neurologist; 2006 Sep; 12(5):263-7. PubMed ID: 16990739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low-dosage acetylsalicylic acid as primary prevention against cardiovascular disease].
    Landmark K
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1937-9. PubMed ID: 11488187
    [No Abstract]   [Full Text] [Related]  

  • 34. [Asasantin Retard or Persantin Retard+ASA?].
    Lindberg M
    Ugeskr Laeger; 2004 Jun; 166(24):2368; author reply 2369-70. PubMed ID: 15281582
    [No Abstract]   [Full Text] [Related]  

  • 35. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
    Morrison CM; Gainsborough N; Rajkumar C
    Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
    [No Abstract]   [Full Text] [Related]  

  • 36. What next for low dose aspirin?
    Morgan G
    J Epidemiol Community Health; 2005 Jan; 59(1):3-4. PubMed ID: 15598718
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticoagulation to prevent strokes in older people with atrial fibrillation: assembling individualized risk and benefit information.
    Fuller R
    J Am Geriatr Soc; 2004 Nov; 52(11):1968-9. PubMed ID: 15507087
    [No Abstract]   [Full Text] [Related]  

  • 38. [Warfarin and ASA combination is impressive. Drugs with old tradition reduce reinfarction and stroke after coronary syndrome].
    Herlitz J
    Lakartidningen; 2006 Jul 26-Aug 8; 103(30-31):2208-9. PubMed ID: 16921972
    [No Abstract]   [Full Text] [Related]  

  • 39. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose of aspirin and bleeding risks.
    Serebruany V
    Am J Cardiol; 2006 Jul; 98(2):275. PubMed ID: 16828608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.